CONDENSED BALANCE SHEETS - USD ($)	Dec. 31, 2020	Sep. 30, 2020
Current Assets:
Cash and cash equivalents	$ 21,860,482	$ 15,508,909
Receivables	54,922	54,922
Prepaid expenses	629,894	1,313,432
Supplies used for R&D and manufacturing	1,152,837	820,052
Total current assets	23,698,135	17,697,315
Finance lease right of use assets	13,382,401	13,811,849
Operating lease right of use assets	1,160,305	1,198,958
Property and equipment, net	9,401,891	5,843,993
Patent costs, net	300,356	313,422
Deposits	1,670,917	1,670,917
Total Assets	49,614,005	40,536,454
Current Liabilities:
Accounts payable	3,092,856	2,023,067
Accrued expenses	616,163	510,515
Due to employees	458,740	448,022
Derivative instruments, current portion	2,040,773	213,787
Lease liabilities, current portion	1,125,337	1,070,123
Total current liabilities	7,333,869	4,265,514
Derivative instruments, net of current portion	750,154	3,551,826
Finance lease obligations, net of current portion	11,495,840	11,753,100
Operating lease obligations, net of current portion	1,073,470	1,114,340
Other liabilities	125,000	125,000
Total liabilities	20,778,333	20,809,780
Commitments and Contingencies	0	0
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value-200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 39,767,058 and 38,730,150 shares issued and outstanding at December 31, 2020 and September 30, 2020, respectively	397,671	387,302
Additional paid-in capital	418,210,168	401,174,675
Accumulated deficit	(389,772,167)	(381,835,303)
Total stockholders' equity	28,835,672	19,726,674
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 49,614,005	$ 40,536,454